Literature DB >> 33791817

ECG and arrhythmias in peripartum cardiomyopathy.

David Duncker1, Tobias J Pfeffer2, Johann Bauersachs2, Christian Veltmann2.   

Abstract

Peripartum cardiomyopathy (PPCM) is a rare but life-threatening heart disease, with onset in the last month of pregnancy or in the first months after delivery. Extensive studies on the burden of supraventricular and ventricular arrhythmias are lacking. Patients with PPCM present with electrocardiographic findings typical in acute heart failure. Management of arrhythmias in PPCM depends on the severity and the onset (during pregnancy or after delivery). Studies on the use of the wearable cardioverter-defibrillator in patients with PPCM show a substantial burden of ventricular tachyarrhythmias and sudden death in patients with severely reduced left ventricular function. The aim of the present article is to summarize actual knowledge on electrocardiogram findings, arrhythmias, and sudden cardiac death in patients with PPCM.

Entities:  

Keywords:  PPCM; Pregnancy; Reduced left ventricular function; Sudden cardiac death; Ventricular tachycardia

Year:  2021        PMID: 33791817     DOI: 10.1007/s00399-021-00760-9

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  28 in total

1.  Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome.

Authors:  Anne S Ersbøll; Marianne Johansen; Peter Damm; Steen Rasmussen; Niels G Vejlstrup; Finn Gustafsson
Journal:  Eur J Heart Fail       Date:  2017-06-08       Impact factor: 15.534

2.  The prognostic value of positive T wave in lead aVR: A novel marker of adverse cardiac outcomes in peripartum cardiomyopathy.

Authors:  Firdevs Aysenur Ekizler; Serkan Cay; Habibe Kafes; Ozcan Ozeke; Firat Ozcan; Serkan Topaloglu; Ahmet Temizhan; Dursun Aras
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-01-17       Impact factor: 1.468

3.  Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.

Authors:  David Duncker; Arash Haghikia; Thorben König; Stephan Hohmann; Klaus-Jürgen Gutleben; Ralf Westenfeld; Hanno Oswald; Helmut Klein; Johann Bauersachs; Denise Hilfiker-Kleiner; Christian Veltmann
Journal:  Eur J Heart Fail       Date:  2014-11-05       Impact factor: 15.534

4.  A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

Authors:  Denise Hilfiker-Kleiner; Karol Kaminski; Edith Podewski; Tomasz Bonda; Arnd Schaefer; Karen Sliwa; Olaf Forster; Anja Quint; Ulf Landmesser; Carola Doerries; Maren Luchtefeld; Valeria Poli; Michael D Schneider; Jean-Luc Balligand; Fanny Desjardins; Aftab Ansari; Ingrid Struman; Ngoc Q N Nguyen; Nils H Zschemisch; Gunnar Klein; Gerd Heusch; Rainer Schulz; Andres Hilfiker; Helmut Drexler
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

5.  [Electrocardiographic recording of long duration (Holter) of 24 hours during idiopathic cardiomyopathy of the peripartum].

Authors:  M Diao; I B Diop; A Kane; S Camara; Ad Kane; M Sarr; S A Ba; S M Diouf
Journal:  Arch Mal Coeur Vaiss       Date:  2004-01

6.  Clinical profile and predictors of complications in peripartum cardiomyopathy.

Authors:  Sorel Goland; Kalgi Modi; Fahed Bitar; Munir Janmohamed; James M Mirocha; Lawrence S C Czer; Sandra Illum; Parta Hatamizadeh; Uri Elkayam
Journal:  J Card Fail       Date:  2009-07-16       Impact factor: 5.712

Review 7.  Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.

Authors:  Johann Bauersachs; Mattia Arrigo; Denise Hilfiker-Kleiner; Christian Veltmann; Andrew J S Coats; Maria G Crespo-Leiro; Rudolf A De Boer; Peter van der Meer; Christoph Maack; Frederic Mouquet; Mark C Petrie; Massimo F Piepoli; Vera Regitz-Zagrosek; Maria Schaufelberger; Petar Seferovic; Luigi Tavazzi; Frank Ruschitzka; Alexandre Mebazaa; Karen Sliwa
Journal:  Eur J Heart Fail       Date:  2016-06-23       Impact factor: 15.534

8.  Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.

Authors:  Johann Bauersachs; Tobias König; Peter van der Meer; Mark C Petrie; Denise Hilfiker-Kleiner; Amam Mbakwem; Righab Hamdan; Alice M Jackson; Paul Forsyth; Rudolf A de Boer; Christian Mueller; Alexander R Lyon; Lars H Lund; Massimo F Piepoli; Stephane Heymans; Ovidiu Chioncel; Stefan D Anker; Piotr Ponikowski; Petar M Seferovic; Mark R Johnson; Alexandre Mebazaa; Karen Sliwa
Journal:  Eur J Heart Fail       Date:  2019-06-27       Impact factor: 15.534

Review 9.  Peripartum cardiomyopathy: current management and future perspectives.

Authors:  Denise Hilfiker-Kleiner; Arash Haghikia; Justus Nonhoff; Johann Bauersachs
Journal:  Eur Heart J       Date:  2015-01-29       Impact factor: 29.983

10.  Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.

Authors:  Denise Hilfiker-Kleiner; Arash Haghikia; Dominik Berliner; Jens Vogel-Claussen; Johannes Schwab; Annegret Franke; Marziel Schwarzkopf; Philipp Ehlermann; Roman Pfister; Guido Michels; Ralf Westenfeld; Verena Stangl; Ingrid Kindermann; Uwe Kühl; Christiane E Angermann; Axel Schlitt; Dieter Fischer; Edith Podewski; Michael Böhm; Karen Sliwa; Johann Bauersachs
Journal:  Eur Heart J       Date:  2017-09-14       Impact factor: 29.983

View more
  1 in total

1.  Usage of the wearable cardioverter-defibrillator during pregnancy.

Authors:  J-Jacqueline Olic; Claudia Stöllberger; Christoph Schukro; Katja E Odening; Edith Reuschel; Marcus Fischer; Christian Veltmann; David Duncker; Andrea Baessler
Journal:  Int J Cardiol Heart Vasc       Date:  2022-06-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.